NICE technology appraisal guidance
Issued: May 2010
TA189
Sorafenib for the treatment of advanced hepatocellular carcinoma
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta189
Important information about this guidance
This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp